Cell Therapy Next Current Issue

2021_12_December

The following articles appeared in the print edition of Cell Therapy Next.

Table of Contents

Outpatient therapy: Bringing CAR T cells closer to home Drew Amorosi
The ‘eharmony of immunotherapy’: Bispecific T-cell engagers vs. CAR-T for multiple myeloma Drew Amorosi
CAR T-cell therapy linked to cardiovascular, pulmonary adverse effects Anthony DeFino
CAR-T plus pembrolizumab ‘promising’ for malignant pleural mesothelioma Drew Amorosi
CAR-T ‘clearly superior’ for triple-class refractory multiple myeloma Drew Amorosi
CRISPR editing can produce ‘life-altering’ changes in patient health, Nobel laureate says Drew Amorosi
Earlier CAR-T treatment possible if price comes down, FDA official says Drew Amorosi
Early data from CAR macrophage trial show cell therapy is safe, feasible for solid tumors Drew Amorosi
Research provides clues to improving CAR-T for solid tumors Drew Amorosi
Tumor-infiltrating lymphocyte cell therapy ‘potentially viable’ option for advanced NSCLC Drew Amorosi